ALFA Finder| Execution period | Effective from FY 2025-26 until FY 2034-35 |
|---|
BSE filing, NSE: SHREEJISPG. Summary written from the filing by ALFA Finder's alert engine.
Shreeji Shipping Global Ltd: key numbers
- Share price
- ₹881.20
- Market cap
- ₹14,356 Cr
- Revenue (annual)
- ₹709.4 Cr
- Net profit (annual)
- ₹152.7 Cr
- P/E (TTM)
- 89.8×Sector 32.3×
- Promoter holding
- 88.00%-2.00% QoQ
- FII holding
- 0.92%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Shreeji Shipping Global Ltd
All →Shreeji Shipping Global Board Meeting Date
Shreeji Shipping will hold a board meeting on 14 November 2026 to consider half-yearly results and a stock split. Trading window stays closed until 16 November 2026.
Shreeji Shipping Global Stock Split
Shreeji Shipping Global will consider a stock split of its Rs 10 face value shares and unaudited results on 14 November 2026. The split still needs shareholder and regulatory approval.
Shreeji Shipping Global IPO
Promoters Ashokkumar and Jitendrakumar Lal sold 30,00,000 shares via the NSE OFS, raising about ₹256.54 Crore. Each now holds 39.93%.
- Value
- ₹256.5 Cr
Shreeji Shipping Global Promoter Selling: ₹256.5 Cr
Promoters Ashokkumar and Jitendra Haridas Lal sold 30,00,000 shares through the NSE OFS window on 3-4 November 2026. Combined sale value is about INR 256.54 Crore.
- Value
- ₹256.5 Cr
Shreeji Shipping Global Promoter Selling
Promoters Ashokkumar and Jitendra Lal propose selling up to 30 lakh shares via NSE offer for sale. The sale aims to meet minimum public shareholding norms.
- Execution
- 3 November 2026 (T day, non-retail) and 4 November 2026 (T+1 day, retail and carry-forward bids)
Shreeji Shipping Global IPO
Promoters Ashokkumar and Jitendra Lal will sell up to 30 lakh Shreeji Shipping shares via OFS on November 3-4, 2026. Floor price Rs 835 implies Rs 250.5 Crore at base size.
- Value
- ₹250.5 Cr
- Execution
- T day November 3, 2026 and T+1 day November 4, 2026
Other regulatory approval announcements
All →Sandur Manganese & Iron Ores Regulatory Approval
Sandur Manganese received environmental clearance to raise iron ore capacity to 9.42 MTPA. No rupee value is disclosed in the filing.
- iron ore RoM capacity
- 9.42 MTPA
Neogen Chemicals Regulatory Approval
Neogen Chemicals received GPCB's revocation of its Dahej plant direction and a CC&A amendment for manufacturing. The revocation is for three months with conditions attached.
Arihant Capital Markets Regulatory Approval
Arihant Capital Markets received SEBI in-principle approval to sponsor and set up a mutual fund. Final registration remains subject to SEBI's conditions.
Dr. Reddy's Laboratories Regulatory Approval
Dr. Reddy's Laboratories received marketing authorization from Brazil's ANVISA for its generic semaglutide injection. The approval targets Brazil's diabetes market, estimated at approximately USD 244.6 million.
Alembic Pharmaceuticals Regulatory Approval
Alembic Pharmaceuticals received USFDA final approval for its generic Olopatadine Hydrochloride Ophthalmic Solution 0.7% ANDA. The product's US market is estimated at $20 million, per IQVIA.
Emmbi Industries Regulatory Approval
SEBI exempted the Makrand and Rinku Appalwar business trusts from SAST takeover rules for an internal family share transfer. Control and promoter shareholding remain unchanged.